Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union
The aim of this meeting is to provide an overview of recent regulatory developments in pharmaceutical regulatory affairs in Russia and the Eurasian Union. This interactive meeting will discuss the regulatory requirements within these regions, and discuss the implications of the new joint Eurasian Union regulation, which came into force in 2016. The focus will be on practical aspects to assist in developing your regulatory strategy for product approval in these countries and the presentations will also give practical hints on the regulatory process where possible.
Benefits of attending
Attending this programme will:
- Give you the full background to the CIS pharmaceutical market
- Ensure that you understanding the full implications of the new regulations which will effect how you do business in the Eurasian Economic Union (EAEU)
- Fully update you on the national regulations in Russia, Belarus, Kazakhstan, Ukraine and other CIS countries